Read the paper that inspired Professor Buse: Frias JP, Davies MJ, Rosenstock J, Manghi FCP, Lando LF, Bergman BK, Liu B, Cui X, Brown K, for the SURPASS-2 Investigators. Tirzepatide versus Semaglutide Once Weekly in Patients with type 2 Diabetes. N Engl J Med 2021;385:503-15. http://pubmed.ncbi.nlm.nih.gov/34170647/ .

 

To hear more from Professor Buse, listen to 5 things we don’t yet know.